Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Galectin Therapeutics

Galectin Therapeutics reported $44K in Interest Income for its fiscal quarter ending in March of 2023.

Interest Income Change
Aceragen Inc IDRA:US USD 48K 63K
Galectin Therapeutics GALT:US USD 44K 14K
Immunic Inc. VTL:US USD 800K 102K
Regulus Therapeutics RGLS:US USD 415K 82K